Fred Hutch researchers launch free online tool to assess colorectal cancer risk Researchers led by Ulrike “Riki” Peters, PhD, MPH, holder of the 40th Anniversary Endowed Chair, and Li Hsu, PhD, ...
Silent mouth changes can turn deadly! Read ahead to know why early detection of oral precancerous lesions can save your life ...
Figures released by the Central Bank of Nigeria show that foreign exchange spent by Nigerians on medical tourism has fallen ...
The American Society for Radiation Oncology (ASTRO) announced today that it rebranded its research foundation, formerly the ...
Multidimensional intervention for patients with lung cancer incorporates rehabilitation, psychosocial support, nutrition guidance, health promotion, and safety surveillance. Multidimensional ...
Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...
PSMAddition is an international, open-label, prospective, phase 3 randomized controlled trial of 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC.
The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...
Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could ...
BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the remaining $35 million anticipated to close in Q1 2026.BioAtla ...